Northern Ireland student spent days in London donating stem cells to save stranger’s life – Belfast Telegraph
Belfast Telegraph |
Northern Ireland student spent days in London donating stem cells to save stranger’s life
Belfast Telegraph “Throughout various placements within hospitals, I had seen first-hand the devastating effect that blood cancer can have on people – the difficulties that can occur in finding a match for a stem cell transplant and the life-changing effect that a … |
Belfast Telegraph |
Northern Ireland student spent days in London donating stem cells to save stranger’s life
Belfast Telegraph “Throughout various placements within hospitals, I had seen first-hand the devastating effect that blood cancer can have on people – the difficulties that can occur in finding a match for a stem cell transplant and the life-changing effect that a … |
|
Vedanta Biosciences to Advance Cancer Immunotherapy Candidates Based on Microbiome-Derived Live …
Business Wire (press release) “Dr. Honda’s research suggests an entirely new approach to cancer immunotherapy harnessing the human microbiome, which has the potential to significantly enhance the effectiveness of cancer therapies,” said Bernat Olle, PhD, Chief Executive Officer of … |
Xconomy |
Sanofi Pulls Back from Voyager Gene Therapy Pact in Parkinson’s
Xconomy A key study for Voyager Therapeutics and its experimental gene therapy for Parkinson’s disease will have to move ahead without help from pharmaceutical giant Sanofi, which has walked away from the deal. Global rights to Parkinson’s treatment VY-AADC01 … Sanofi walks away from Voyager’s phase 2/3 Parkinson’s gene therapyBSA bureau (press release) |
Xconomy |
Sanofi Pulls Back from Voyager Gene Therapy Pact in Parkinson’s
Xconomy A key study for Voyager Therapeutics and its experimental gene therapy for Parkinson’s disease will have to move ahead without help from pharmaceutical giant Sanofi, which has walked away from the deal. Global rights to Parkinson’s treatment VY-AADC01 … Sanofi walks away from Voyager’s phase 2/3 Parkinson’s gene therapyBSA bureau (press release) |
Xconomy |
Sanofi Pulls Back from Voyager Gene Therapy Pact in Parkinson’s
Xconomy A key study for Voyager Therapeutics and its experimental gene therapy for Parkinson’s disease will have to move ahead without help from pharmaceutical giant Sanofi, which has walked away from the deal. Global rights to Parkinson’s treatment VY-AADC01 … Sanofi walks away from Voyager’s phase 2/3 Parkinson’s gene therapyBSA bureau (press release) |
Alabama’s News Leader |
Chelsea clinic introduces oral immunotherapy for nut allergies
Alabama’s News Leader Last year, Laura started oral immunotherapy treatment to help desensitize her allergy to tree nuts. “This offers the therapy that allows them to get the food back in the diet safely, as long as it’s continued,” said Dr. Carolyn Comer, Medical Director … |